NeoGenomics, Inc. (NASDAQ:NEO)

About the company

NeoGenomics, Inc. is a clinical laboratory company, which specializes in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Sector

Health Services

Industry

Medical and Nursing Services

Employees

1700

$419.00M

Total Revenue

2K

Employees

$4B

Market Capitalization

847.00

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$196M

Operating Margin (in %)

Total operating margin

$5M

Net Margin (in %)

Total net margin

$3M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
DaVita, Inc. DVA 11671.20 11487.00 5.07 12.95 7.85
Chemed Corp. CHE 8152.35 1992.00 11.13 34.28 11.60
Guardant Health, Inc. GH 7770.15 245.00 10.52 -100.66 -31.53
Amedisys, Inc. AMED 6856.41 1980.00 9.90 53.97 6.43
LHC Group, Inc. LHCG 5555.20 2091.00 3.96 56.53 4.73
1Life Healthcare, Inc. ONEM 4827.06 292.00 10.38 -60.81 -27.31
NeoGenomics, Inc. NEO 3591.28 419.00 7.37 847.00 0.82
Natera, Inc. NTRA 3509.84 330.00 14.61 -28.28 -38.27
SmileDirectClub, Inc. SDC 3207.05 769.00 10.16 -26.03 -16.02
Invitae Corp. NVTA 3119.04 241.00 12.45 -10.22 -125.90
The Ensign Group, Inc. ENSG 2376.08 2155.00 3.37 19.20 5.76
Acadia Healthcare Co., Inc. ACHC 2250.16 3130.00 0.92 19.98 3.61
MEDNAX, Inc. MD 1449.18 3508.00 1.00 -1.14 -36.30
Addus HomeCare Corp. ADUS 1264.90 598.00 2.99 61.46 3.33
U.S. Physical Therapy, Inc. USPH 1056.38 478.00 4.33 35.96 6.03
RadNet, Inc. RDNT 778.50 1164.00 6.36 389.25 0.18
Castle Biosciences, Inc. CSTL 675.07 61.00 8.75 661.83 9.75
The Pennant Group, Inc. PNTG 640.64 352.00 8.38 152.53 1.19
Option Care Health, Inc. OPCH 627.36 2539.00 2.65 -6.41 -3.63
Hanger, Inc. HNGR 612.18 1095.00 -38.36 32.88 1.71
Tivity Health, Inc. TVTY 540.00 1255.00 70.31 -1.09 -38.98
Catasys, Inc. CATS 440.13 41.00 -16.08 -14.15 -74.67
Fulgent Genetics, Inc. FLGT 324.20 35.00 4.32 -1621.00 -1.31
OptiNose, Inc. OPTN 237.79 37.00 7.18 -2.16 -295.66
American Renal Associates Holdings, Inc. ARA 205.12 824.00 -2.54 -11.45 -2.19
Aptinyx, Inc. APTX 170.28 4.00 1.76 -3.05 -810.48
Exagen, Inc. XGN 165.75 41.00 3.19 -5.18 -76.21
CRH Medical Corp. CRHM 163.52 117.00 2.15 112.00 1.52
Pro-Dex, Inc. PDEX 71.72 31.00 3.98 16.30 14.50
Guardion Health Sciences, Inc. GHSI 35.70 1.00 2.62 -1.56 -824.43
Cardiff Oncology, Inc. CRDF 30.17 0.00 12.31 -1.97 -883.77
OncoSec Medical, Inc. ONCS 25.61 None 2.10 -0.68 None
Biocept, Inc. BIOC 24.27 6.00 3.76 -0.89 -463.58
Capital Senior Living Corp. CSU 20.16 439.00 -0.64 -0.29 -16.00
American Shared Hospital Services AMS 12.66 20.00 0.46 52.75 1.28
IMAC Holdings, Inc. IMAC 10.98 16.00 1.26 -1.63 -42.30
TrovaGene, Inc. TROV 8.04 0.00 2.03 -0.48 -883.77

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Hedge Funds Are Souring On NeoGenomics, Inc. (NEO)

2d ago, source: YAHOO!

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use ...

NeoGenomics, Inc.: NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients

7d ago, source: Finanznachrichten

FT. MYERS, FL / ACCESSWIRE / June 29, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today the launch of three liquid biopsy tests for ...

NeoGenomics launches solid tumor liquid biopsy tests

7d ago, source: Seeking Alpha

NeoGenomics (NEO +5.3%) launches three liquid biopsy tests for advanced non-small cell lung cancer, all solid tumor types (pan-cancer), and certain breast cancer cases. These new tests provide a ...

US Commercial Launch of InVisionFirst®-Lung

7d ago, source: YAHOO!

Research Triangle Park, NC, USA and Cambridge, UK June 29, 2020 – Inivata, a leader in liquid biopsy, today announces that NeoGenomics, Inc (NASDAQ: NEO), its strategic commercialization partner in ...

Hedge Funds Getting Bullish On Riverview Bancorp, Inc. (RVSB)

2d ago, source: Yahoo! News

With this in mind, let’s take a look at the recent hedge fund activity surrounding Riverview Bancorp, Inc. (NASDAQ:RVSB) and determine whether hedge funds had an edge regarding this stock. Hedge funds ...

NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients

7d ago, source: Digital Journal

FT. MYERS, FL / ACCESSWIRE / June 29, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today the launch of three liquid biopsy tests ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.